Reference is made to the stock exchange announcements from SoftOx Solutions AS
(the "Company") on 16 December 2020 regarding the successful completion of a
private placement and the contemplated repair issue to be carried out. 
The subsequent offering was approved by the Company's extraordinary general
meeting on 4 January 2021 (the "Subsequent Offering"). 

For the purposes of the Subsequent Offering, the Company has prepared a national
prospectus (the "Prospectus"). The Prospectus has today been registered in the
Norwegian Register of Business Enterprises (Nw: Foretaksregisteret). The
Prospectus will be published on 17 February 2021 prior to the start of the
Subscription Period, and can be obtained electronically by downloading it from
www.soft-ox.com, www.sb1markets.no, or by contacting the Company or SpareBank 1
Markets AS (the "Manager"). 

The Subsequent Offering comprises an offer of up to 181,818 new shares in the
Company (the "Offer Shares") at an offer price of NOK 55 per Offer Share, which
equals the subscription price in the Private Placement announced by the Company
on 16 December 2020. Total gross proceeds will amount to approximately NOK
9,999,990 million if all the Offer Shares are allocated. 

The Company will, subject to applicable securities laws, grant non-transferable
subscription rights to subscribe for Offer Shares to shareholders in the Company
as of close of trading on 16 December 2020 as registered in the Norwegian
Central Securities Depository (the "VPS") on 18 December 2020 (the "Record
Date") who were not allocated shares in the Private Placement and who are not
resident in a jurisdiction where such offering would be unlawful, or for
jurisdictions other than Norway, would require any filing, registration or
similar action (the "Eligible Shareholders"). Eligible Shareholders will be
granted 0.0279 Subscription Rights for each share held. Each Subscription Right
will give the right to subscribe for one Offer Share. Over-subscription and
subscription without Subscription Rights will be permitted.

The subscription period in the Subsequent Offering commences on 17 February 2021
at 09:00 hours and will expire on 3 March 2021 at 16:30 hours CET (the
"Subscription Period").
 
In order to subscribe for shares, the Manager must receive a complete and duly
signed subscription form within the end of the Subscription Period. Further
instructions regarding the subscription procedure is available in the
Prospectus. Subscription Rights not used to subscribe for Offer Shares prior to
16:30 hours on 3 March 2021 will have no value and will lapse without
compensation to the holder.

Notifications of allocated Offer Shares and the corresponding subscription
amount to be paid by each subscriber are expected to be distributed on or about
4 March 2021. 

The payment for Offer Shares allocated to a subscriber falls due on 8 March 2021
(the "Payment Date"). Delivery of the Offer Shares to investors' VPS accounts is
expected to take place on or about 15 March 2021.

In addition to the Subsequent Offering, the Board of Directors has resolved that
up to 181,818 new shares will, subject to applicable prospectus requirements and
available exemptions, be offered to eligible employees, the members of the board
of directors and certain invited hired external consultants of the Company at
the same subscription price as in the Private Placement and the Subsequent
Offering. The shares offered to employees will be issued by the board of
directors under the authorisation to issue shares granted by the general meeting
on 4 January 2021.  

SpareBank 1 Markets AS are acting as Manager in connection with the Subsequent
Offering. Advokatfirmaet Wiersholm AS acts as legal advisor to as the Company in
connection with the Subsequent Offering.

For more information regarding the Subsequent Offering, please refer to the
Prospectus available from 17 February 2021 on the Company's website
www.soft-ox.com. 

For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: +47 948 59 599 

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth, Oslo) is a Norwegian
MedTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com